TNF-α is released from host cells during the initial onset of acute GvHD and enhances CD8+ T cell cytotoxic response (36), thereby intensifying the severity of the disease and compromising the pathways to graft immune tolerance. This evidence concerns the gene TNF and graft versus host disease.